Fampridine for MS responders: clinically relevant or hypothesis generating?
Kryscio
Richard J
RJ
D015761:4-Aminopyridine / Q000008:administration & dosage*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D026902:Potassium Channel Blockers / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D026902:Potassium Channel Blockers; D015761:4-Aminopyridine